Madrigal Pharmaceuticals
Christopher Brill is an experienced executive in the pharmaceutical and biotechnology sectors, currently serving as the Executive Director of IT - Commercial Operations at Madrigal Pharmaceuticals since March 2024. With a career spanning over two decades, Christopher has held significant roles, including Senior Manager at EY, where expertise was developed in government pricing and compliance issues for the pharmaceutical industry. Christopher's previous positions also include Senior Director at Teva Pharmaceuticals, focusing on core commercial systems, and consulting roles at Pfizer, Wyeth, and Accenture, emphasizing government pricing solutions and system implementations. Christopher holds a Bachelor of Science in Electrical Engineering from Penn State University and an Associate's degree in Sociology from Montgomery County Community College.
This person is not in the org chart
Madrigal Pharmaceuticals
4 followers
Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need.